Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2019 Jun 5

PMID 31163321

Citations 95

Authors

Man Wang

Fei Yu

Han Ding

Yu Wang

Peifeng Li

Kun Wang

Affiliations

Soon will be listed here.

Abstract

Exosomes are a subset of membrane-bound extracellular vesicles with diameters ranging from 30 to 100 nm. Exosomes enclose a variety of molecules, such as lipids, proteins, and non-coding RNAs. In the past decades, microRNAs (miRNAs) have attracted great attention in cancer research, as they play an important role in the occurrence and development of cancer. Increasing evidence indicates that tumor cells communicate with not only other tumor cells but also cells present in the tumor microenvironment via secretion and transfer of exosomal miRNAs. More importantly, exosomal miRNAs are found to serve as signaling molecules to regulate tumor growth, angiogenesis, metastasis, sensitivity to chemotherapy, and immune evasion. Deregulated expression of exosomal miRNAs is an early event in carcinogenesis and may reflect the malignant characteristics of cancer. Owing to the wide existence and high stability of exosomal miRNAs in body fluids, they may represent a novel class of non-invasive biomarkers for cancer. In this review, we highlight the recent advances on the functional role of exosomal miRNAs in cancer pathogenesis. We also discuss the potential clinical utility of exosome-shuttled miRNAs as biomarkers for the diagnosis and treatment of cancer.

Citing Articles

Unlocking the potential of exosomes: A new frontier in liver cancer liquid biopsy.

Das A, Nyahatkar S, Sonar S, Kalele K, Subramaniyan V J Liq Biopsy. 2025; 6:100166.

PMID: 40027309 PMC: 11863868. DOI: 10.1016/j.jlb.2024.100166.

Role of the AKT signaling pathway in regulating tumor-associated macrophage polarization and in the tumor microenvironment: A review.

Liang C, Wang S, Wu C, Wang J, Xu L, Wan S Medicine (Baltimore). 2025; 104(5):e41379.

PMID: 39889181 PMC: 11789917. DOI: 10.1097/MD.0000000000041379.

A game of hide-and-seek: how extracellular vesicles evade the immune system.

Ghoshal B, Jhunjhunwala S Drug Deliv Transl Res. 2025; .

PMID: 39843837 DOI: 10.1007/s13346-025-01789-w.

Immunomodulatory role of EV-derived non-coding RNA in lung cancer.

Ghidotti P, Petraroia I, Fortunato O, Pontis F Extracell Vesicles Circ Nucl Acids. 2024; 4(1):59-71.

PMID: 39698297 PMC: 11648522. DOI: 10.20517/evcna.2022.42.

Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers.

Kang K, Gim J, Hong S, Kim H, Choi Y, Park J PLoS One. 2024; 19(8):e0306962.

PMID: 39178208 PMC: 11343415. DOI: 10.1371/journal.pone.0306962.

References

Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R . MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012; 109(31):E2110-6. PMC: 3412003. DOI: 10.1073/pnas.1209414109. View

Razi M, Futter C . Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol Biol Cell. 2006; 17(8):3469-83. PMC: 1525239. DOI: 10.1091/mbc.e05-11-1054. View

Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y . Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat. 2014; 147(2):423-31. DOI: 10.1007/s10549-014-3037-0. View

Yuwen D, Sheng B, Liu J, Wenyu W, Shu Y . MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2017; 21(11):2650-2658. View

Palmero E, de Campos S, Campos M, de Souza N, Guerreiro I, Carvalho A . Mechanisms and role of microRNA deregulation in cancer onset and progression. Genet Mol Biol. 2011; 34(3):363-70. PMC: 3168173. DOI: 10.1590/S1415-47572011000300001. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Roszer T . Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm. 2015; 2015:816460. PMC: 4452191. DOI: 10.1155/2015/816460. View

Gernapudi R, Yao Y, Zhang Y, Wolfson B, Roy S, Duru N . Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res Treat. 2015; 150(3):685-95. PMC: 4385483. DOI: 10.1007/s10549-015-3326-2. View

Wang Y, Yang H, Shi X, Wang Y . Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer. Cancer Biol Ther. 2018; 19(12):1162-1173. PMC: 6301807. DOI: 10.1080/15384047.2018.1491497. View

10.

Taverna S, Amodeo V, Saieva L, Russo A, Giallombardo M, De Leo G . Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells. Mol Cancer. 2014; 13:169. PMC: 4105877. DOI: 10.1186/1476-4598-13-169. View

11.

Ambs S, Prueitt R, Yi M, Hudson R, Howe T, Petrocca F . Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008; 68(15):6162-70. PMC: 2597340. DOI: 10.1158/0008-5472.CAN-08-0144. View

12.

Bobrie A, Krumeich S, Reyal F, Recchi C, Moita L, Seabra M . Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012; 72(19):4920-30. DOI: 10.1158/0008-5472.CAN-12-0925. View

13.

Tahiri A, Leivonen S, Luders T, Steinfeld I, Aure M, Geisler J . Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis. 2013; 35(1):76-85. DOI: 10.1093/carcin/bgt333. View

14.

Bhome R, Goh R, Bullock M, Pillar N, Thirdborough S, Mellone M . Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. Aging (Albany NY). 2017; 9(12):2666-2694. PMC: 5764398. DOI: 10.18632/aging.101355. View

15.

Ostrowski M, Carmo N, Krumeich S, Fanget I, Raposo G, Savina A . Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2009; 12(1):19-30. DOI: 10.1038/ncb2000. View

16.

Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y . Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013; 108(3):644-52. PMC: 3593570. DOI: 10.1038/bjc.2013.8. View

17.

Wei Y, Li M, Cui S, Wang D, Zhang C, Zen K . Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes. Molecules. 2016; 21(6). PMC: 6274101. DOI: 10.3390/molecules21060777. View

18.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

19.

Hu Y, Li D, Wu A, Qiu X, Di W, Huang L . TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA. Cancer Lett. 2017; 393:60-67. DOI: 10.1016/j.canlet.2017.02.009. View

20.

Yan S, Liu G, Jin C, Wang Z, Duan Q, Xu J . MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer. J Cell Physiol. 2017; 233(9):6660-6668. DOI: 10.1002/jcp.26316. View